Article
The Clearance of Human Cytomegalovirus Using CRISPR/Cas9 RNA Lipid Nanoparticles
2025-12-17
Abstract excerpt
Human cytomegalovirus (HCMV), a DNA virus, poses significant health risks to immunocompromised and immunosuppressed individuals and newborns. Clinical antiviral drugs like ganciclovir inhibit viral replication but have toxicities, are ineffective against drug-resistant strains, and cannot destroy HCMV DNA. CRISPR/Cas9 can cleave DNA, but has not been used therapeutically to target and degrade HCMV DNA in cells pos...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e7f2f911-5383-5e85-84bc-c5ea2e24aa5f
- DOI
- 10.64898/2025.12.17.694960
